Silence Therapeutics plc (SLNCF) Operating cash flow 2022–2025
Silence Therapeutics plc (SLNCF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$62.3MFY2025 · since FY2022: -$57.0M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.3M | +7.9% |
| FY2024 | -$67.6M | -36.8% |
| FY2023 | -$49.5M | +13.3% |
| FY2022 | -$57.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLNCF financial trends
SLNCF RevenueSLNCF Net incomeSLNCF Net marginSLNCF Gross profitSLNCF Gross marginSLNCF Operating incomeSLNCF Operating marginSLNCF Free cash flowSLNCF Capital expendituresSLNCF Return on equitySLNCF Stock buybacksSLNCF Dividends paidSLNCF Total assetsSLNCF Total liabilitiesSLNCF Shareholders’ equitySLNCF overview →